A multicenter, double-blind, dose-ranging, randomized, placebo-controlled study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis: radiologic progression and correlation of Genant and Larsen scores.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples